KINTARA THERAPEUTICS INC (KTRA)
US49720K2006 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 183.36% | N/A 69.15% | N/A 70.02% | |||||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | -6.2M | -8.3M -33.87% | -11.15M -34.34% | -8.38M 24.84% | -8.14M 2.86% | -37.64M -362.41% | -22.62M 39.90% | -14.74M 34.84% | -8.396M 43.04% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.71M | -6.29M -132.10% | -4.72M 24.96% | -6.21M -31.57% | -8.32M -33.98% | -11.17M -34.25% | -8.4M 24.80% | -8.15M 2.98% | -37.67M -362.21% | -22.68M 39.79% | -14.8M 34.74% | -8.451M 42.90% | N/A -136.11% | N/A -1.00% | N/A 37.57% | N/A 55.68% | N/A 196.73% | N/A 359.29% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -420.00 | -360.00 14.29% | -275.00 23.61% | N/A 46.96% | N/A 79.72% | -39.00 -31.85% | -25.50 34.62% | -9.49 62.78% | N/A 95.06% | N/A 17.39% | N/A 2.63% | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -1.83 47.71% | -0.59 | -1.24 | -209.33% |
| Q4 2023 Q2Q % growth | -1.95 64.55% | -1.08 | -0.87 | -81.21% |
| Q3 2023 Q2Q % growth | -1.94 64.73% | -0.19 | -1.75 | -901.03% |
| Q2 2023 Q2Q % growth | -2.10 65.00% | -3.23 | 1.13 | 34.95% |
| Q1 2023 Q2Q % growth | -3.50 58.82% | 0.00 | -3.50 | % |
| Q4 2022 Q2Q % growth | -5.50 15.38% | -1.53 | -3.97 | -259.48% |
| Q3 2022 Q2Q % growth | -5.50 52.17% | -7.65 | 2.15 | 28.10% |
| Q2 2022 Q2Q % growth | -6.00 45.45% | -8.16 | 2.16 | 26.47% |
| Q1 2022 Q2Q % growth | -8.50 15.00% | -7.40 | -1.10 | -14.94% |
| Q4 2021 Q2Q % growth | -6.50 60.61% | -8.16 | 1.66 | 20.34% |
| Q3 2021 Q2Q % growth | -11.50 -35.29% | -9.31 | -2.19 | -23.56% |
| Q2 2021 Q2Q % growth | -11.00 -46.67% | -7.27 | -3.73 | -51.36% |
| Q1 2021 Q2Q % growth | -10.00 | -4.59 | -5.41 | -117.86% |
| Q4 2020 Q2Q % growth | -16.50 62.92% | -5.95 | -10.55 | -177.30% |
| Q3 2020 Q2Q % growth | -8.50 | -6.38 | -2.13 | -33.33% |
| Q2 2020 Q2Q % growth | -7.50 | -8.93 | 1.43 | 15.97% |
| Q4 2019 Q2Q % growth | -44.50 11.00% | -31.11 | -13.39 | -43.04% |
| Q4 2018 Q2Q % growth | -50.00 | -56.10 | 6.10 | 10.87% |
| Q3 2018 Q2Q % growth | -65.00 | -51.00 | -14.00 | -27.45% |
| Q2 2018 Q2Q % growth | -70.00 | -76.50 | 6.50 | 8.50% |
| Q1 2018 Q2Q % growth | -90.00 | -86.70 | -3.30 | -3.81% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | 4.808M | -4.808M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |